Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Toyooka

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Less maintenance immunosuppression in lung transplantation following hematopoietic stem cell transplantation from the same living donorF Chen, M Yamane, M Inoue, et al.
Spinal Cord|January 25, 2012
Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot studyK Hayakawa, R Okazaki, K Ishii, et al.
Cancer Research|December 26, 2001
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological featuresR Maruyama, S Toyooka, K O Toyooka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2019
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancerH Yoshioka, M Shimokawa, T Seto, et al.
Molecular Cancer Therapeutics|December 7, 2002
DNA methylation profiles of lung tumorsS Toyooka, K O Toyooka, R Maruyama, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humansH Ariyasu, K Takaya, T Tagami, et al.
Journal of the National Cancer Institute|May 3, 2001
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionD G Burbee, E Forgacs, S Zöchbauer-Müller, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Less maintenance immunosuppression in lung transplantation following hematopoietic stem cell transplantation from the same living donorF Chen, M Yamane, M Inoue, et al.
Spinal Cord|January 25, 2012
Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot studyK Hayakawa, R Okazaki, K Ishii, et al.
Cancer Research|December 26, 2001
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological featuresR Maruyama, S Toyooka, K O Toyooka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2019
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancerH Yoshioka, M Shimokawa, T Seto, et al.
Molecular Cancer Therapeutics|December 7, 2002
DNA methylation profiles of lung tumorsS Toyooka, K O Toyooka, R Maruyama, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humansH Ariyasu, K Takaya, T Tagami, et al.
Journal of the National Cancer Institute|May 3, 2001
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionD G Burbee, E Forgacs, S Zöchbauer-Müller, et al.
Pageof 4